mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.2 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |